Public Profile

Antibody Solutions Inc.

Antibody Solutions Inc., a leading player in the biotechnology sector, is headquartered in the United States and operates across various regions, providing innovative solutions in antibody development and production. Founded in 2003, the company has established itself as a trusted partner for researchers and pharmaceutical companies, offering a comprehensive range of services, including custom antibody generation, protein production, and assay development. What sets Antibody Solutions apart is its commitment to quality and efficiency, utilising advanced technologies to deliver high-specificity antibodies tailored to client needs. With a strong market position, the company has achieved notable milestones, including collaborations with prominent institutions and contributions to significant scientific advancements. Antibody Solutions Inc. continues to drive innovation in the field, making it a preferred choice for those seeking reliable and effective antibody solutions.

DitchCarbon Score

How does Antibody Solutions Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

24

Industry Benchmark

Antibody Solutions Inc.'s score of 23 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.

49%

Antibody Solutions Inc.'s reported carbon emissions

Antibody Solutions Inc., headquartered in the US, currently does not have available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined by the company. In the absence of concrete emissions data, it is essential to note that many companies in the biotechnology sector are increasingly focusing on sustainability and climate commitments. This trend often includes setting science-based targets for emissions reductions and implementing initiatives to minimise their carbon footprint. As the industry evolves, it is likely that Antibody Solutions Inc. will align with these practices to enhance its environmental responsibility.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Antibody Solutions Inc.'s primary industry is Research and development services (73), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Antibody Solutions Inc. is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Antibody Solutions Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Similar Organizations

Genscript Biotech Corporation

CN
Research and development services (73)
Updated 14 days ago

Genovac GmbH

DE
Updated 21 days ago

ImmunoPrecise Antibodies Ltd.

CA
Health and social work services (85)
Updated 14 days ago

Abveris Inc.

US
Chemicals nec
Updated about 1 month ago
DitchCarbon Score

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers